856 related articles for article (PubMed ID: 25437566)
21. p97 Homologs from Caenorhabditis elegans, CDC-48.1 and CDC-48.2, suppress the aggregate formation of huntingtin exon1 containing expanded polyQ repeat.
Nishikori S; Yamanaka K; Sakurai T; Esaki M; Ogura T
Genes Cells; 2008 Aug; 13(8):827-38. PubMed ID: 18782221
[TBL] [Abstract][Full Text] [Related]
22. Molecular chaperone functions in protein folding and proteostasis.
Kim YE; Hipp MS; Bracher A; Hayer-Hartl M; Hartl FU
Annu Rev Biochem; 2013; 82():323-55. PubMed ID: 23746257
[TBL] [Abstract][Full Text] [Related]
23. Defining the limits: Protein aggregation and toxicity in vivo.
Holmes WM; Klaips CL; Serio TR
Crit Rev Biochem Mol Biol; 2014; 49(4):294-303. PubMed ID: 24766537
[TBL] [Abstract][Full Text] [Related]
24. The struggle by Caenorhabditis elegans to maintain proteostasis during aging and disease.
Kikis EA
Biol Direct; 2016 Nov; 11(1):58. PubMed ID: 27809888
[TBL] [Abstract][Full Text] [Related]
25. Molecular chaperones biochemistry and role in neurodegenerative diseases.
Chaari A
Int J Biol Macromol; 2019 Jun; 131():396-411. PubMed ID: 30853582
[TBL] [Abstract][Full Text] [Related]
26. Quality control of the proteins associated with neurodegenerative diseases.
Gao X; Hu H
Acta Biochim Biophys Sin (Shanghai); 2008 Jul; 40(7):612-8. PubMed ID: 18604452
[TBL] [Abstract][Full Text] [Related]
27. Protein aggregation in cell biology: An aggregomics perspective of health and disease.
Cox D; Raeburn C; Sui X; Hatters DM
Semin Cell Dev Biol; 2020 Mar; 99():40-54. PubMed ID: 29753879
[TBL] [Abstract][Full Text] [Related]
28. When proteostasis goes bad: Protein aggregation in the cell.
Radwan M; Wood RJ; Sui X; Hatters DM
IUBMB Life; 2017 Feb; 69(2):49-54. PubMed ID: 28066979
[TBL] [Abstract][Full Text] [Related]
29. Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones?
Muchowski PJ
Neuron; 2002 Jul; 35(1):9-12. PubMed ID: 12123602
[TBL] [Abstract][Full Text] [Related]
30. The inhibition of IGF-1 signaling promotes proteostasis by enhancing protein aggregation and deposition.
Moll L; Ben-Gedalya T; Reuveni H; Cohen E
FASEB J; 2016 Apr; 30(4):1656-69. PubMed ID: 26722006
[TBL] [Abstract][Full Text] [Related]
31. Fluc-EGFP reporter mice reveal differential alterations of neuronal proteostasis in aging and disease.
Blumenstock S; Schulz-Trieglaff EK; Voelkl K; Bolender AL; Lapios P; Lindner J; Hipp MS; Hartl FU; Klein R; Dudanova I
EMBO J; 2021 Oct; 40(19):e107260. PubMed ID: 34410010
[TBL] [Abstract][Full Text] [Related]
32. Glucose delays age-dependent proteotoxicity.
Tauffenberger A; Vaccaro A; Aulas A; Vande Velde C; Parker JA
Aging Cell; 2012 Oct; 11(5):856-66. PubMed ID: 22734670
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of aging-related proteinopathies in Caenorhabditis elegans.
Kim DK; Kim TH; Lee SJ
Exp Mol Med; 2016 Oct; 48(10):e263. PubMed ID: 27713398
[TBL] [Abstract][Full Text] [Related]
34. Neurodegenerative disorders: dysregulation of a carefully maintained balance?
Swart C; Haylett W; Kinnear C; Johnson G; Bardien S; Loos B
Exp Gerontol; 2014 Oct; 58():279-91. PubMed ID: 25219768
[TBL] [Abstract][Full Text] [Related]
35. Extracellular protein homeostasis in neurodegenerative diseases.
Wilson MR; Satapathy S; Vendruscolo M
Nat Rev Neurol; 2023 Apr; 19(4):235-245. PubMed ID: 36828943
[TBL] [Abstract][Full Text] [Related]
36. Nanoparticulate air pollution disrupts proteostasis in Caenorhabditis elegans.
Garcia Manriquez BA; Papapanagiotou JA; Strysick CA; Green EH; Kikis EA
PLoS One; 2023; 18(2):e0275137. PubMed ID: 36821635
[TBL] [Abstract][Full Text] [Related]
37. Proteomic analysis of protein homeostasis and aggregation.
Laskowska E; Kuczyńska-Wiśnik D; Lipińska B
J Proteomics; 2019 Apr; 198():98-112. PubMed ID: 30529741
[TBL] [Abstract][Full Text] [Related]
38. Bacteria-Derived Protein Aggregates Contribute to the Disruption of Host Proteostasis.
Walker AC; Bhargava R; Dove AS; Brust AS; Owji AA; Czyż DM
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563197
[TBL] [Abstract][Full Text] [Related]
39. [Molecular therapy targeting protein misfolding and aggregation for the polyglutamine diseases].
Nagai Y
Rinsho Shinkeigaku; 2009 Nov; 49(11):913-6. PubMed ID: 20030247
[TBL] [Abstract][Full Text] [Related]
40. Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin.
Wang H; Lim PJ; Yin C; Rieckher M; Vogel BE; Monteiro MJ
Hum Mol Genet; 2006 Mar; 15(6):1025-41. PubMed ID: 16461334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
